Mina Sooch - Sep 6, 2022 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
President and CEO, Director
Signature
/s/ Stephanie Swan, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Sep 6, 2022
Transactions value $
$0
Form type
4
Date filed
9/8/2022, 04:01 PM
Previous filing
May 23, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Exercise of in-the-money or at-the-money derivative security $0.10 +1.02K +0.24% $0.00* 426K Sep 6, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Series B Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -1.02K -100% $0.00* 0 Sep 6, 2022 Common Stock 1.02K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The expiration date of the Series B Warrants occurred on the later of (x) the Reservation Date (as defined in the Series B Warrants) and (y) the date on which the Series B Warrant has been exercised in full.